Journal of Cell Science, Vol 108, Issue 6 2285-2292, Copyright © 1995 by Company of Biologists

JOURNAL ARTICLES

The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts

D Zhang, N Udagawa, I Nakamura, H Murakami, S Saito, K Yamasaki, Y Shibasaki, N Morii, S Narumiya, N Takahashi and al. et
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

Rho protein (rho p21), a p21ras-related small guanine nucleotide binding protein, regulates cytoskeletal organization in a number of different types of cells. Evidence has indicated that Clostridium botulinum-derived ADP-ribosyltransferase (C3 exoenzyme) specifically ADP-ribosylates rho p21 at Asn41 and renders it functionally inactive. In this study, we examined the involvement of rho p21 in osteoclastic bone resorption using the C3 exoenzyme. When osteoclast-like multinucleated cells obtained from cocultures of mouse osteoblastic cells and bone marrow cells were placed on dentine slices, they formed ringed structures of podosomes containing F-actin (corresponding to the clear zone) within 8 hours. Many resorption pits were formed on dentine slices after culture for 24 hours. The C3 exoenzyme at 0.15-10 micrograms/ml added to the culture medium disrupted the ringed structure of podosomes in osteoclast-like cells in a dose-dependent manner. Correspondingly, pit formation by osteoclast-like cells on dentine slices was dose-dependently inhibited also by adding the C3 exoenzyme. Microinjection of the C3 exoenzyme into osteoclast-like cells placed on culture dishes completely disrupted the ringed podosome structure within 20 minutes. The amount of the rho p21 which was ADP-ribosylated by the C3 exoenzyme in vitro was much greater in purified osteoclast-like cells than in osteoblastic cells. Prior exposure of the purified osteoclast-like cell preparation to the C3 exoenzyme in vivo markedly decreased the amount of unribosylated rho p21. This indicated that the C3 exoenzyme incorporated into osteoclast-like cells effectively ADP-ribosylates rho p21 in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D.B. Kimmel Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates J. Dent. Res., November 1, 2007; 86(11): 1022 - 1033. [Abstract] [Full Text] [PDF]

				R. G. G. Russell Bisphosphonates: Mode of Action and Pharmacology Pediatrics, March 1, 2007; 119(Supplement_2): S150 - S162. [Abstract] [Full Text] [PDF]

				R. G. G. RUSSELL Bisphosphonates: From Bench to Bedside Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 367 - 401. [Abstract] [Full Text] [PDF]

				J.-J. Body, T. Pfister, and F. Bauss Preclinical Perspectives on Bisphosphonate Renal Safety Oncologist, October 1, 2005; 10(suppl_1): 3 - 7. [Abstract] [Full Text] [PDF]

				C. D. Morris and T. A. Einhorn Bisphosphonates in Orthopaedic Surgery J. Bone Joint Surg. Am., July 1, 2005; 87(7): 1609 - 1618. [Abstract] [Full Text] [PDF]

				O. Destaing, F. Saltel, B. Gilquin, A. Chabadel, S. Khochbin, S. Ory, and P. Jurdic A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts J. Cell Sci., July 1, 2005; 118(13): 2901 - 2911. [Abstract] [Full Text] [PDF]

				A. Y. Kolyada, K. N. Riley, and I. M. Herman Rho GTPase signaling modulates cell shape and contractile phenotype in an isoactin-specific manner Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1116 - C1121. [Abstract] [Full Text] [PDF]

				V. Moreau, F. Tatin, C. Varon, and E. Genot Actin Can Reorganize into Podosomes in Aortic Endothelial Cells, a Process Controlled by Cdc42 and RhoA Mol. Cell. Biol., October 1, 2003; 23(19): 6809 - 6822. [Abstract] [Full Text] [PDF]

				D. Santini, U. Vespasiani Gentilucci, B. Vincenzi, A. Picardi, F. Vasaturo, A. La Cesa, N. Onori, S. Scarpa, and G. Tonini The antineoplastic role of bisphosphonates: from basic research to clinical evidence Ann. Onc., October 1, 2003; 14(10): 1468 - 1476. [Abstract] [Full Text] [PDF]

				H. Kajiya, F. Okamoto, H. Fukushima, K. Takada, and K. Okabe Mechanism and role of high-potassium-induced reduction of intracellular Ca2+ concentration in rat osteoclasts Am J Physiol Cell Physiol, August 1, 2003; 285(2): C457 - C466. [Abstract] [Full Text] [PDF]

				H. Ha, H. B. Kwak, S. K. Lee, D. S. Na, C. E. Rudd, Z. H. Lee, and H.-H. Kim Membrane Rafts Play a Crucial Role in Receptor Activator of Nuclear Factor kappa B Signaling and Osteoclast Function J. Biol. Chem., May 9, 2003; 278(20): 18573 - 18580. [Abstract] [Full Text] [PDF]

				T. Sugatani, U. Alvarez, and K. A. Hruska PTEN Regulates RANKL- and Osteopontin-stimulated Signal Transduction during Osteoclast Differentiation and Cell Motility J. Biol. Chem., February 7, 2003; 278(7): 5001 - 5008. [Abstract] [Full Text] [PDF]

				A. V. SOMLYO, C. PHELPS, C. DIPIERRO, M. ETO, P. READ, M. BARRETT, J. J. GIBSON, M. C. BURNITZ, C. MYERS, and A. P. SOMLYO Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants FASEB J, February 1, 2003; 17(2): 223 - 234. [Abstract] [Full Text] [PDF]

				M. A. Chellaiah, R. S. Biswas, D. Yuen, U. M. Alvarez, and K. A. Hruska Phosphatidylinositol 3,4,5-Trisphosphate Directs Association of Src Homology 2-containing Signaling Proteins with Gelsolin J. Biol. Chem., December 7, 2001; 276(50): 47434 - 47444. [Abstract] [Full Text] [PDF]

				G. S. MARKOWITZ, G. B. APPEL, P. L. FINE, A. Z. FENVES, N. R. LOON, S. JAGANNATH, J. A. KUHN, A. D. DRATCH, and V. D. D'AGATI Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1164 - 1172. [Abstract] [Full Text]

				M. A. Chellaiah, N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S. F. Dowdy, and K. A. Hruska Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption J. Biol. Chem., April 14, 2000; 275(16): 11993 - 12002. [Abstract] [Full Text] [PDF]

				M. Chellaiah, N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski, and K. A. Hruska Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength J. Cell Biol., February 21, 2000; 148(4): 665 - 678. [Abstract] [Full Text] [PDF]

				S Ory, Y Munari-Silem, P Fort, and P Jurdic Rho and Rac exert antagonistic functions on spreading of macrophage-derived multinucleated cells and are not required for actin fiber formation J. Cell Sci., January 4, 2000; 113(7): 1177 - 1188. [Abstract] [PDF]

				H. L. Benford, J. C. Frith, S. Auriola, J. Mönkkönen, and M. J. Rogers Farnesol and Geranylgeraniol Prevent Activation of Caspases by Aminobisphosphonates: Biochemical Evidence for Two Distinct Pharmacological Classes of Bisphosphonate Drugs Mol. Pharmacol., July 1, 1999; 56(1): 131 - 140. [Abstract] [Full Text]

				W. Allen, G. Jones, J. Pollard, and A. Ridley Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages J. Cell Sci., January 3, 1997; 110(6): 707 - 720. [Abstract] [PDF]